Structures by: Görbitz C. H.
Total: 230
Butyl 3-(3,5-di-<i>tert</i>-butyl-4-hydroxyphenyl)propanoate
C21H34O3
IUCrData (2019) 4, 2 x190289
a=9.871(4)Å b=10.973(5)Å c=18.067(7)Å
α=90° β=91.908(14)° γ=90°
L-aminobutanoic acid
C4H9NO2
IUCrJ (2016) 3, 5
a=9.6246(7)Å b=5.2079(4)Å c=43.103(3)Å
α=90° β=100.201(2)° γ=90°
L-aminobutanoic acid
C4H9NO2
IUCrJ (2016) 3, 5
a=9.6132(6)Å b=5.2239(3)Å c=22.4134(16)Å
α=90° β=101.453(2)° γ=90°
L-aminobutanoic acid
C4H9NO2
IUCrJ (2016) 3, 5
a=9.6176(9)Å b=5.2126(5)Å c=21.768(2)Å
α=90° β=101.123(3)° γ=90°
L-aminobutanoic acid
C4H9NO2
IUCrJ (2016) 3, 5
a=9.6233(12)Å b=5.2274(6)Å c=22.877(3)Å
α=90° β=100.764(4)° γ=90°
L-norleucine
C6H13NO2
IUCrJ (2016) 3, 5
a=9.5327(7)Å b=5.2545(4)Å c=14.9590(10)Å
α=90° β=97.628(2)° γ=90°
L-norleucine
C6H13NO2
IUCrJ (2016) 3, 5
a=9.6033(15)Å b=5.2223(8)Å c=15.983(3)Å
α=90° β=90.916(5)° γ=90°
L-methionine
C5H11NO2S
IUCrJ (2016) 3, 5
a=9.5118(6)Å b=5.1936(4)Å c=15.3419(10)Å
α=90° β=97.635(2)° γ=90°
(1S,6S,7S,8R)-8-Butyl-7-((3,5-dinitrobenzoyl)oxymethyl)bicyclo[4.3.0]non-3-ene
C21H26N2O6
Organic & biomolecular chemistry (2016) 14, 36 8433-8437
a=10.866(5)Å b=5.196(2)Å c=18.617(10)Å
α=90° β=106.703(11)° γ=90°
L-Valyl-L-alanine
C8.41H16N2O3
CrystEngComm (2005) 7, 111 670
a=14.4539(18)Å b=14.4539(18)Å c=9.996(3)Å
α=90.00° β=90.00° γ=120.00°
L-Valyl-L-alanine acetonitrile solvate 0.85 hydrate
C8.67H17.57N2.33O3.29
CrystEngComm (2005) 7, 111 670
a=13.7281(5)Å b=10.1400(4)Å c=13.8928(6)Å
α=90.00° β=118.5780(10)° γ=90.00°
L-Valyl-L-serine trifluoroethanol solvate
C8.28H16F0.85N2O4.13
CrystEngComm (2005) 7, 111 670
a=14.0668(13)Å b=9.8053(10)Å c=14.1915(14)Å
α=90.00° β=116.172(2)° γ=90.00°
L-Valyl-L-serine trifluoroethanol solvate
C8.55H15.94N2O4.08
CrystEngComm (2005) 7, 111 670
a=14.0999(14)Å b=9.8140(10)Å c=14.2142(14)Å
α=90.00° β=116.140(2)° γ=90.00°
Tetrakis(4-thyminylmethylphenyl)methane
C49H44N8O8
CrystEngComm (2018) 20, 9 1179
a=14.9614(17)Å b=15.2536(16)Å c=30.990(4)Å
α=90° β=96.288(3)° γ=90°
Tetrakis(4-thyminylmethylphenyl)methane
C49H44N8O8,0.5(CH4O)
CrystEngComm (2018) 20, 9 1179
a=14.4613(17)Å b=20.326(2)Å c=23.303(3)Å
α=65.194(3)° β=85.341(3)° γ=73.765(3)°
2,2'-Bipyridine-5,5'-dicarboxylate.Bis(1,3,4,6,7,8-Hexahydro-2H-pyrimido[1,2-a] pyrimidinium)
C6H3NO2.C7H14N3.H4O4.708
CrystEngComm (2013) 15, 3 439
a=32.122(17)Å b=15.681(8)Å c=7.105(4)Å
α=90.00° β=90.00° γ=90.00°
C12H6N2O4,2(C7H14N3),4(H2O)
C12H6N2O4,2(C7H14N3),4(H2O)
CrystEngComm (2013) 15, 3 439
a=8.5504(12)Å b=9.4858(13)Å c=10.3928(14)Å
α=66.7490(10)° β=69.2570(10)° γ=89.901(2)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66513(16)Å b=9.0127(4)Å c=9.7723(5)Å
α=109.318(4)° β=102.263(3)° γ=100.163(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66521(18)Å b=8.9987(4)Å c=9.7696(5)Å
α=109.516(4)° β=102.251(3)° γ=100.096(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66107(17)Å b=8.9574(5)Å c=9.7578(5)Å
α=109.831(5)° β=102.228(4)° γ=99.913(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66062(16)Å b=8.9394(4)Å c=9.7525(5)Å
α=109.967(4)° β=102.224(3)° γ=99.833(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.65706(14)Å b=8.9064(4)Å c=9.7446(4)Å
α=110.208(4)° β=102.193(3)° γ=99.702(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.65949(16)Å b=8.9271(4)Å c=9.7495(4)Å
α=110.093(4)° β=102.220(3)° γ=99.769(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.65476(17)Å b=8.8702(4)Å c=9.7344(4)Å
α=110.377(4)° β=102.167(3)° γ=99.621(3)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2748(2)Å b=6.6507(3)Å c=10.4397(3)Å
α=86.836(3)° β=76.833(3)° γ=70.093(4)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2705(3)Å b=6.6419(4)Å c=10.4243(5)Å
α=86.895(4)° β=76.869(4)° γ=70.160(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2644(3)Å b=6.6233(4)Å c=10.3965(4)Å
α=87.021(4)° β=76.908(4)° γ=70.282(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2672(3)Å b=6.6328(4)Å c=10.4111(4)Å
α=86.956(4)° β=76.887(4)° γ=70.227(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2615(3)Å b=6.6145(4)Å c=10.3827(4)Å
α=87.080(4)° β=76.924(4)° γ=70.335(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2563(3)Å b=6.5980(3)Å c=10.3562(4)Å
α=87.226(4)° β=76.973(4)° γ=70.438(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2540(3)Å b=6.5904(3)Å c=10.3425(4)Å
α=87.327(4)° β=77.009(4)° γ=70.477(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2521(2)Å b=6.5844(3)Å c=10.3311(2)Å
α=87.440(3)° β=77.032(3)° γ=70.505(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.08996(15)Å b=5.8843(2)Å c=6.5214(2)Å
α=96.452(3)° β=103.859(3)° γ=102.076(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.07618(15)Å b=5.8583(2)Å c=6.5043(2)Å
α=96.300(3)° β=103.661(3)° γ=102.203(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.06381(14)Å b=5.83621(18)Å c=6.4864(2)Å
α=96.162(3)° β=103.409(3)° γ=102.331(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.04324(14)Å b=5.80332(17)Å c=6.4627(2)Å
α=95.944(3)° β=103.086(3)° γ=102.516(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.05300(17)Å b=5.81773(18)Å c=6.4717(2)Å
α=96.051(3)° β=103.212(3)° γ=102.439(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66264(17)Å b=8.9788(4)Å c=9.7642(4)Å
α=109.682(4)° β=102.236(3)° γ=100.002(3)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2589(3)Å b=6.6056(4)Å c=10.3687(4)Å
α=87.155(4)° β=76.947(4)° γ=70.385(5)°
Ethylene-9,9'-diadenine
C12H12N10,4(C3H2F6O)
CrystEngComm (2016) 18, 34 6352
a=7.1752(7)Å b=10.3078(10)Å c=12.3995(12)Å
α=86.613(2)° β=87.488(2)° γ=71.906(2)°
9-methyladenine dihexafluoro-2-propanol solvate
C6H7N5,2(C3H2F6O)
CrystEngComm (2016) 18, 34 6352
a=12.150(3)Å b=12.921(3)Å c=13.546(3)Å
α=113.938(5)° β=101.075(6)° γ=96.166(6)°
Zr-metallorganic
C22H26Cl2Si2Zr
Dalton transactions (Cambridge, England : 2003) (2004) 10 1578-1589
a=10.6354(1)Å b=13.4550(2)Å c=16.3064(1)Å
α=90.00° β=98.783(1)° γ=90.00°
Bis(2-(trimethylsilyl)indenyl)zirconium(IV) dichloride
C24H30Cl2Si2Zr
Dalton transactions (Cambridge, England : 2003) (2004) 10 1578-1589
a=9.7631(6)Å b=34.995(3)Å c=8.1505(7)Å
α=90.00° β=112.415(2)° γ=90.00°
L-allo-isoleucine:D-leucine
C6H13NO2,C6H13NO2
Physical chemistry chemical physics : PCCP (2010) 12, 30 8466-8477
a=5.23570(10)Å b=5.42510(10)Å c=13.5733(2)Å
α=87.4160(10)° β=88.9940(10)° γ=69.4310(10)°
L-norvaline:D-methionine
C5H11NO2,C5H11NO2S
Physical chemistry chemical physics : PCCP (2010) 12, 30 8466-8477
a=9.89650(10)Å b=4.69630(10)Å c=16.11880(10)Å
α=90.00° β=106.9890(10)° γ=90.00°
L-aminobutyric acid:D-norleucine
C4H9NO2,C6H13NO2
Physical chemistry chemical physics : PCCP (2010) 12, 30 8466-8477
a=5.1725(3)Å b=5.3955(3)Å c=12.3952(7)Å
α=92.631(2)° β=94.747(2)° γ=113.103(2)°
1,5,7-triazabicyclo[4.4.0]dec-5-ene.oxalicacid
C7H14N3,C2HO4
CrystEngComm (2013) 15, 36 7321
a=7.8795(16)Å b=9.760(2)Å c=13.612(3)Å
α=90.00° β=90.00° γ=90.00°
1,5,7-triazabicyclo[4.4.0]dec-5-ene.adipic acid
C6H9O4,C7H14N3
CrystEngComm (2013) 15, 36 7321
a=7.014(3)Å b=12.065(5)Å c=17.179(7)Å
α=90.00° β=90.118(6)° γ=90.00°
1,5,7-triazabicyclo[4.4.0]dec-5-ene.glycolicacid
C7H14N3,C2H3O3,H2O
CrystEngComm (2013) 15, 36 7321
a=7.1832(7)Å b=8.9257(9)Å c=9.8008(10)Å
α=71.2980(10)° β=75.3740(10)° γ=81.2030(10)°
N-isopropyl-L-valine
C8H17NO2
CrystEngComm (2014) 16, 41 9631
a=5.378(2)Å b=9.788(4)Å c=8.399(3)Å
α=90.00° β=101.676(4)° γ=90.00°
N-Isopropyl-DL-valine
C8H17NO2
CrystEngComm (2014) 16, 41 9631
a=17.382(4)Å b=10.705(2)Å c=9.608(2)Å
α=90.00° β=90.00° γ=90.00°
N-benzyl-L-valine
C12H17NO2
CrystEngComm (2014) 16, 41 9631
a=5.766(3)Å b=12.082(5)Å c=16.559(7)Å
α=90° β=90° γ=90°
N-isopropyl-L-phenylalanine
C12H17NO2
CrystEngComm (2014) 16, 41 9631
a=10.750(2)Å b=9.407(2)Å c=11.079(3)Å
α=90.00° β=95.013(3)° γ=90.00°
L-alanyl-L-valine
C8H16N2O3
CrystEngComm (2010) 12, 8 2322
a=14.4270(17)Å b=14.4270(17)Å c=10.0102(15)Å
α=90° β=90° γ=120°
L-alanyl-L-valine
C8H16N2O3
CrystEngComm (2010) 12, 8 2322
a=13.9836(19)Å b=13.9836(19)Å c=9.9229(15)Å
α=90° β=90° γ=120°
L-methionine
C5H11NO2S
IUCrJ (2016) 3, 5
a=9.5473(6)Å b=5.1830(3)Å c=15.5830(10)Å
α=90° β=94.980(2)° γ=90°
<i>L</i>-2-Aminobutyric acid--<i>D</i>-methionine (1/1) <i>L</i>-Abu:<i>D</i>-Met
C4H9NO2,C5H11NO2S
Acta Crystallographica Section C (2016) 72, 7 536-543
a=9.4890(15)Å b=9.8774(15)Å c=15.079(2)Å
α=71.429(4)° β=75.650(4)° γ=89.369(4)°
<i>L</i>-2-Aminobutyric acid:<i>D</i>-methionine <i>L</i>-Abu:<i>D</i>-Met
C4H9NO2,C5H11NO2S
Acta Crystallographica Section C (2016) 72, 7 536-543
a=29.1721(18)Å b=4.7784(3)Å c=9.8551(6)Å
α=90° β=103.145(2)° γ=90°
L-Abu
C4H9NO2
Acta Crystallographica Section B (2010) 66, 2 253-259
a=9.614(6)Å b=5.227(3)Å c=21.385(13)Å
α=90.00° β=100.326(7)° γ=90.00°
L-Abu
C4H9NO2
Acta Crystallographica Section B (2010) 66, 2 253-259
a=9.646(2)Å b=5.2145(12)Å c=42.885(10)Å
α=90.00° β=100.295(3)° γ=90.00°
Diethylstilbestrol tert-butanol solvate (1/4)
C18H20O2,4(C4H10O)
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=6.2717(6)Å b=7.4330(8)Å c=20.364(2)Å
α=85.140(2)° β=85.031(2)° γ=82.626(2)°
Diethylstilbestrol acetonitrile solvate (1/1)
C18H20O2,C2H3N
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=7.5866(2)Å b=8.9294(2)Å c=13.4851(3)Å
α=95.762(1)° β=106.263(1)° γ=101.386(1)°
Diethylstilbestrol dimethylsulfoxide solvate (1/1)
C18H20O2,C2H6OS
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=7.8841(5)Å b=9.1401(5)Å c=13.6505(8)Å
α=90.975(2)° β=105.924(2)° γ=100.892(2)°
Diethylstilbestrol N,N-dimethylformamide solvate (1/1)
C18H20O2,C3H7NO
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=7.6393(1)Å b=9.9833(3)Å c=13.3161(1)Å
α=91.883(2)° β=104.036(1)° γ=104.311(1)°
Diethylstilbestrol 2-propanol solvate (1/1)
C18H20O2,C3H8O
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=5.6981(2)Å b=21.1274(7)Å c=16.0891(6)Å
α=90.00° β=90.914(2)° γ=90.00°
Diethylstilbestrol acetone solvate (1/1)
C18H20O2,C3H6O
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=9.6266(15)Å b=13.662(2)Å c=15.365(2)Å
α=69.979(2)° β=77.853(2)° γ=83.927(3)°
Diethylstilbestrol etanol solvate dihydrate (1/1/2)
C18H20O2,C2H6O,2(H2O)
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=7.7092(4)Å b=8.9320(5)Å c=15.3466(8)Å
α=93.797(2)° β=100.629(2)° γ=98.866(2)°
Diethylstilbestrol methanol solvate hydrate (1/1/0.79)
C18H20O2,CH4O,0.79(H2O)
Acta Crystallographica Section B (2000) 56, 6 1094-1102
a=7.5712(6)Å b=9.1543(7)Å c=13.5964(10)Å
α=73.691(3)° β=75.460(3)° γ=80.517(3)°
L-Val-L-Phe dihydrate
C14H24N2O5
Acta Crystallographica, Section B (2002) 58, 3 512-518
a=5.6595(4)Å b=8.3306(6)Å c=33.022(2)Å
α=90.00° β=90.00° γ=90.00°
L-Val-L-Phe trihydrate
C14H26N2O6
Acta Crystallographica, Section B (2002) 58, 3 512-518
a=10.3137(3)Å b=45.2095(12)Å c=15.5891(4)Å
α=90.00° β=105.1710(10)° γ=90.00°
Glycyl-L-serine
C5H10N2O4
Acta Crystallographica Section B (1999) 55, 6 1090-1098
a=7.275(2)Å b=9.097(3)Å c=10.507(3)Å
α=90.00° β=90.00° γ=90.00°
Glycyl-L-serine
C5H10N2O4
Acta Crystallographica Section B (1999) 55, 6 1090-1098
a=7.275(2)Å b=9.097(3)Å c=10.507(3)Å
α=90.00° β=90.00° γ=90.00°
Glycyl-L-serine
C5H10N2O4
Acta Crystallographica Section B (1999) 55, 6 1090-1098
a=7.275(2)Å b=9.097(3)Å c=10.507(3)Å
α=90.00° β=90.00° γ=90.00°
Glycyl-L-serine
C5H10N2O4
Acta Crystallographica Section B (1999) 55, 6 1090-1098
a=7.275(2)Å b=9.097(3)Å c=10.507(3)Å
α=90.00° β=90.00° γ=90.00°
Glycyl-L-serine
C5H10N2O4
Acta Crystallographica Section B (1999) 55, 6 1090-1098
a=7.275(2)Å b=9.097(3)Å c=10.507(3)Å
α=90.00° β=90.00° γ=90.00°
C6H13NO2
C6H13NO2
Acta Crystallographica Section B (2000) 56, 4 720-727
a=5.22890(10)Å b=5.41020(10)Å c=13.1095(3)Å
α=96.3320(10)° β=90.6220(10)° γ=109.4930(10)°
DL-Allylglycine
C5H9NO2
Acta Crystallographica Section B (2000) 56, 4 715-719
a=9.8588(5)Å b=4.8125(3)Å c=25.0546(13)Å
α=90.00° β=90.00° γ=90.00°
C6H13NO2
C6H13NO2
Acta Crystallographica Section B (2000) 56, 4 720-727
a=9.67060(10)Å b=5.25830(10)Å c=14.1018(2)Å
α=90.000° β=98.0330(10)° γ=90.000°
C6H13NO2
C6H13NO2
Acta Crystallographica Section B (2000) 56, 4 720-727
a=5.24930(10)Å b=5.40060(10)Å c=13.2778(2)Å
α=92.9433(6)° β=92.8659(5)° γ=109.8571(7)°
L-Ala-L-Val
C8H16N2O3
Acta Crystallographica Section B (2002) 58, 5 849-854
a=14.2957(3)Å b=14.2957(3)Å c=9.9077(2)Å
α=90.00° β=90.00° γ=120.00°
L-Ala-L-Val methanol solvate
C10H16N2O3
Acta Crystallographica Section B (2002) 58, 5 849-854
a=14.3102(10)Å b=14.3102(10)Å c=9.8997(7)Å
α=90.00° β=90.00° γ=120.00°
L-Ala-L-Val acetonitrile solvate
C8.7H17.05N2.35O3
Acta Crystallographica Section B (2002) 58, 5 849-854
a=14.1635(8)Å b=14.1635(8)Å c=9.8702(5)Å
α=90.00° β=90.00° γ=120.00°
L-Ala-L-Val 2-propanol solvate
C8.51H15.6N2O3.44
Acta Crystallographica Section B (2002) 58, 5 849-854
a=28.7247(16)Å b=28.7247(16)Å c=9.9009(8)Å
α=90.00° β=90.00° γ=120.00°
L-Val-L-Leu
C11H22N2O3,C2H3N
Acta Crystallographica Section B (2018) 74, 3 311-318
a=5.341(3)Å b=13.536(6)Å c=21.406(8)Å
α=90° β=90° γ=90°
L-Isoleucyl-L-isoleucine dihydrate
C12H28N2O5
Acta Crystallographica Section B (2004) 60, 5 569-577
a=7.6341(3)Å b=12.5335(6)Å c=16.3923(7)Å
α=90.00° β=90.00° γ=90.00°
Ammonium L-Leucyl-L-Leucinate
C12H27N3O3
Acta Crystallographica Section B (2004) 60, 5 569-577
a=6.7765(15)Å b=9.718(2)Å c=11.882(3)Å
α=81.580(3)° β=80.484(3)° γ=88.350(3)°
L-Isoleucyl-L-isoleucine nitrate
C13.08H25N3O6
Acta Crystallographica Section B (2004) 60, 5 569-577
a=16.0682(6)Å b=16.0682(6)Å c=11.5317(9)Å
α=90.00° β=90.00° γ=120.00°
L-Isoleucyl-L-isoleucine L-Isoleucyl-L-isoleucinium nitrate acetonitrile solvate
C13.8H27.2N3.4O4.7
Acta Crystallographica Section B (2004) 60, 5 569-577
a=16.2957(19)Å b=23.426(2)Å c=9.5842(9)Å
α=90.00° β=90.00° γ=90.00°
L-valyl-L-glutamine
C10H19N3O4
Acta Crystallographica Section B (1996) 52, 6 999-1006
a=16.419(3)Å b=15.309(3)Å c=4.7080(10)Å
α=90.00° β=90.00° γ=90.00°
L-Glu-L-Val
C10H18N2O5
Acta Crystallographica Section B (1996) 52, 6 999-1006
a=6.487(2)Å b=5.505(2)Å c=16.741(4)Å
α=90.00° β=97.22(2)° γ=90.00°
(<i>S</i>)-2-[(3<i>S</i>,8<i>S</i>,9<i>S</i>,10<i>R</i>,13<i>S</i>,14<i>S</i>,17<i>R</i>)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl]-<i>N</i>-methoxy-<i>N</i>-methylpropanamide
C24H39NO3
Acta Crystallographica Section E (2015) 71, 3 275-277
a=7.7256(4)Å b=19.0030(9)Å c=29.8162(15)Å
α=90° β=90° γ=90°
DL-methionine
C5H11NO2S
Acta Crystallographica Section E (2015) 71, 6 o398-o399
a=31.774(2)Å b=4.6969(3)Å c=9.8939(7)Å
α=90° β=91.224(2)° γ=90°